Inhibition of Chlamydia pneumoniae replication in human aortic smooth muscle cells by gamma interferon-induced

Related Experiment Video

Updated: Aug 16, 2026

Expansion of Human Peripheral Blood γδ T Cells using Zoledronate
13:08

Expansion of Human Peripheral Blood γδ T Cells using Zoledronate

Published on: September 9, 2011

L G Pantoja1, R D Miller, J A Ramirez

  • 1Division of Infectious Diseases, Department of Medicine, University of Louisville School of Medicine, Louisville, Kentucky 40292, USA.

Infection and Immunity
|October 18, 2000
PubMed

Insights

Gamma interferon (IFN-γ) activates indoleamine 2,3-dioxygenase (IDO) in aortic cells. This enzyme inhibits Chlamydia pneumoniae growth by increasing tryptophan breakdown, potentially impacting atherosclerosis.

Area of Science:

  • Immunology
  • Microbiology
  • Cardiovascular Science

Background:

  • Chlamydia pneumoniae infection is linked to atherosclerosis.
  • Persistent forms of Chlamydia may contribute to chronic diseases.
  • Aortic smooth muscle cells are key in atherosclerosis development.

Purpose of the Study:

  • To determine if gamma interferon (IFN-γ) induces indoleamine 2,3-dioxygenase (IDO) in aortic smooth muscle cells.
  • To investigate if IDO activity inhibits Chlamydia pneumoniae growth.
  • To explore the role of tryptophan metabolism in this inhibition.

Main Methods:

  • Treatment of aortic smooth muscle cells with IFN-γ.
  • Measurement of IDO mRNA expression and enzymatic activity.
  • Assessment of Chlamydia pneumoniae replication in treated cells.
  • Analysis of tryptophan levels and catabolism.

Main Results:

  • IFN-γ significantly increased IDO mRNA expression and enzymatic activity in aortic smooth muscle cells.
  • IDO activation led to increased tryptophan catabolism.
  • Increased tryptophan catabolism resulted in dose-dependent inhibition of Chlamydia pneumoniae replication.

Conclusions:

  • IFN-γ induces IDO in aortic smooth muscle cells, enhancing tryptophan metabolism.
  • IDO-mediated tryptophan depletion effectively inhibits Chlamydia pneumoniae growth.
  • This mechanism may offer a new perspective on managing C. pneumoniae infections in the context of atherosclerosis.

More Related Videos

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

Imaging of In Situ Interferon Gamma Production in the Mouse Spleen following Listeria monocytogenes Infection09:11

Imaging of In Situ Interferon Gamma Production in the Mouse Spleen following Listeria monocytogenes Infection

Published on: July 16, 2019

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...